Results 171 to 180 of about 48,358 (306)

Establishing a Standard Method for Screening Lymphatic Ultrasound in Lymphedema Patients. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Kukreja-Pandey S   +4 more
europepmc   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar   +6 more
wiley   +1 more source

Editorial: Sex differences and cardiovascular therapeutics

open access: yesFrontiers in Cardiovascular Medicine
Fatma Saaoud   +8 more
doaj   +1 more source

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐07261271 in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim There is an unmet need for more effective therapies in inflammatory bowel disease (IBD). A single drug that blocks multiple distinct pathogenic pathways may offer therapeutic benefit superior to current monotherapies. PF‐07261271, a bispecific antibody targeting both the p40 subunit of interleukin‐12/23 and tumour necrosis factor‐like cytokine 1A ...
Srividya Neelakantan   +11 more
wiley   +1 more source

Spatially Resolved Heterogeneity of Lymphatic Vasculature in the Adult Lung-Brief Report. [PDF]

open access: yesArterioscler Thromb Vasc Biol
Crossey E   +9 more
europepmc   +1 more source

Purification of Advanced Therapeutics by Flow‐Through Pseudo‐Affinity Chromatography: Bi‐Specific mABs, Fc Fusion Proteins, and Adeno‐Associated Viruses

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Modern biopharmaceutical manufacturing requires purification platforms capable of processing structurally and functionally diverse products while addressing the challenge of removing persistent and high‐risk host cell proteins (HCPs).
Wenning Chu   +23 more
wiley   +1 more source

Editorial: Clinical trials in cardiovascular medicine: 2025—addressing residual cardiovascular risks through precision-guided approaches

open access: yesFrontiers in Cardiovascular Medicine
Euscia Y. Wang   +10 more
doaj   +1 more source

Macrophage-mediated refinement of the dural lymphatic regulates social behavior. [PDF]

open access: yesNeuron
Tavares GA   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy